Leonard S. Schleifer, President & CEO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 5,772 shares at $710.01 ($4.1M) on 2022-03-31, disclosed to the SEC on 2022-04-04.
Open-market sale of $4.1M REGN by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $710.01 | 2,886 | $2.0M | 50.0% |
| 2 | $710.01 | 2,886 | $2.0M | 50.0% |
| Total | $710.01 avg | 5,772 | $4.1M | 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |